Efficacy of laryngeal botulinum toxin injection: Comparison of two techniques

Laryngoscope

Volumn 121, Issue 9, 2011, Pages 1924-1928

  Fulmer, Susan L ^a   Merati, Albert L ^b   Blumin, Joel H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

botulinum toxin; injection technique; Larynx; spasmodic dysphonia

Indexed keywords

BOTULINUM TOXIN A;

ADDUCTOR SPASMODIC DYSPHONIA; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTROMYOGRAPHY; FEMALE; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POINT TOUCH TECHNIQUE; PRIORITY JOURNAL; SPASMODIC DYSPHONIA;

BOTULINUM TOXINS, TYPE A; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VOICE DISORDERS;

EID: 80052087153     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.21966     Document Type: Article

References (16)

1. Ludlow CL, Adler CH, Berke GS, et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg 2008; 139: 495-505.
2. Sulica L,. Contemporary management of spasmodic dysphonia. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 543-548. (Pubitemid 39565212)
3. Blitzer A, Brin MF, Fahn S, Lange D, Lovelace RE,. Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias. Laryngoscope 1986; 96: 1300-1301.
4. Brin MF, Blitzer A, Stewart C,. Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin. Adv Neurol 1998; 78: 237-252.
5. Ford CN, Bless DM, Lowery JD,. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia. Otolaryngol Head Neck Surg 1990; 103: 752-758.
6. Sataloff RT, Mandel S, Mann EA, Ludlow CL, AAEM Laryngeal Task F,. Laryngeal electromyography: an evidence-based review. Muscle Nerve 2003; 28: 767-772. (Pubitemid 37484843)
7. Green DC, Berke GS, Ward PH, Gerratt BR,. Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia. Ann Otol Rhinol Laryngol 1992; 101: 883-887.
8. Galardi G, Guerriero R, Amadio S, et al. Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia. Neurol Sci 2001; 22: 303-306. (Pubitemid 34071564)
9. Blitzer A, Brin MF, Fahn S, Lovelace RE,. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope 1988; 98: 193-197. (Pubitemid 18052677)
10. Tucker HM,. Laryngeal framework surgery in the management of spasmodic dysphonia. Preliminary report. Ann Otol Rhinol Laryngol 1989; 98: 52-54. (Pubitemid 19039597)
11. Bielamowicz S, Squire S, Bidus K, Ludlow CL,. Assessment of posterior cricoarytenoid botulinum toxin injections in patients with abductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 2001; 110: 406-412. (Pubitemid 32433850)
12. Meleca RJ, Hogikyan ND, Bastian RW,. A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia. Otolaryngol Head Neck Surg 1997; 117: 487-492. (Pubitemid 27508140)
13. Barbano RL,. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is useful. Muscle Nerve 2001; 24: 1567-1568.
14. Jankovic J,. Needle EMG guidance for injection of botulinum toxin. Needle EMG guidance is rarely required. Muscle Nerve 2001; 24: 1568-1570.
15. Shaari CM, George E, Wu BL, Biller HF, Sanders I,. Quantifying the spread of botulinum toxin through muscle fascia. Laryngoscope 1991; 101: 960-964.
16. Shaari CM, Sanders I,. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993; 16: 964-969. (Pubitemid 23246323)